Literature DB >> 9789220

Loss of heterozygosity on chromosome 6q27 and p53 mutations in epithelial ovarian cancer.

M Suzuki1, S Saito, Y Saga, M Ohwada, I Sato.   

Abstract

Loss of heterozygosity (LOH) in chromosome region 6q27 and p53 mutations were studied to attempt to clarify the genetic etiology of ovarian cancer, with particular reference to clear cell adenocarcinoma (CCC), which has a poor prognosis. 6q27 LOH in 70 epithelial ovarian cancer patients was examined using four restriction fragment length polymorphism markers located at 6q27; p53 mutations in tumor DNA were detected using polymerase chain reaction single-strand conformation polymorphism and sequencing. 6q27 LOH was confirmed in 26 of 48 informative cases (54.2%). No differences in the incidence of 6q27 LOH were seen by histologic type; 6q27 LOH was observed in 45% (5/11) of CCCs. p53 mutations were detected in 19 of the 48 tumors (39.6%), but in only one (9%) CCC. These results suggest that a putative tumor suppressor gene involved in the onset of epithelial ovarian cancer is located at 6q27. This gene is one of the keys to clarifying the genetic etiology of epithelial ovarian cancer and particularly CCC, given the low incidence of p53 mutations in this tumor type.

Entities:  

Mesh:

Year:  1998        PMID: 9789220     DOI: 10.1007/bf02989590

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  26 in total

1.  p53 gene mutation in human borderline epithelial ovarian tumors.

Authors:  I Wertheim; M G Muto; W R Welch; D A Bell; R S Berkowitz; S C Mok
Journal:  J Natl Cancer Inst       Date:  1994-10-19       Impact factor: 13.506

2.  3 distinct regions of chromosome-6 are targets of loss of heterozygosity in human ovarian carcinomas.

Authors:  M Wan; S Zweizig; G Dablaing; J Zheng; M Velicescu; L Dubeau
Journal:  Int J Oncol       Date:  1994-11       Impact factor: 5.650

3.  Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer.

Authors:  I E Cooke; A N Shelling; V G Le Meuth; M L Charnock; T S Ganesan
Journal:  Genes Chromosomes Cancer       Date:  1996-04       Impact factor: 5.006

4.  Human epithelial ovarian cancer allelotype.

Authors:  W Cliby; S Ritland; L Hartmann; M Dodson; K C Halling; G Keeney; K C Podratz; R B Jenkins
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

5.  p53 mutation is a common genetic event in ovarian carcinoma.

Authors:  B J Milner; L A Allan; D M Eccles; H C Kitchener; R C Leonard; K F Kelly; D E Parkin; N E Haites
Journal:  Cancer Res       Date:  1993-05-01       Impact factor: 12.701

6.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

7.  p53 mutations in ovarian cancer: a late event?

Authors:  R Mazars; P Pujol; T Maudelonde; P Jeanteur; C Theillet
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

8.  Aberrations of the p53 tumor suppressor gene in human epithelial ovarian carcinoma.

Authors:  J W Kim; Y H Cho; D J Kwon; T E Kim; T C Park; J M Lee; S E Namkoong
Journal:  Gynecol Oncol       Date:  1995-05       Impact factor: 5.482

9.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

Authors:  T Sato; A Tanigami; K Yamakawa; F Akiyama; F Kasumi; G Sakamoto; Y Nakamura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

Review 10.  The genetic analysis of ovarian cancer.

Authors:  A N Shelling; I E Cooke; T S Ganesan
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

View more
  1 in total

Review 1.  The consequence of oncomorphic TP53 mutations in ovarian cancer.

Authors:  Pavla Brachova; Kristina W Thiel; Kimberly K Leslie
Journal:  Int J Mol Sci       Date:  2013-09-23       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.